Gateway Investment Advisers LLC Decreases Position in Avantor, Inc. (NYSE:AVTR)

Gateway Investment Advisers LLC decreased its position in Avantor, Inc. (NYSE:AVTR) by 45.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 111,662 shares of the company’s stock after selling 91,360 shares during the period. Gateway Investment Advisers LLC’s holdings in Avantor were worth $2,353,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. UMB Bank n.a. purchased a new position in shares of Avantor in the third quarter worth about $49,000. Nisa Investment Advisors LLC grew its stake in Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after buying an additional 835 shares in the last quarter. GAMMA Investing LLC raised its holdings in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after acquiring an additional 1,285 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Avantor by 278.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after acquiring an additional 3,700 shares in the last quarter. Finally, ORG Wealth Partners LLC bought a new position in shares of Avantor in the third quarter worth $139,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on AVTR. Wells Fargo & Company decreased their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. UBS Group reissued a “neutral” rating and issued a $25.00 price target (down from $29.00) on shares of Avantor in a report on Friday. Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Barclays lowered their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Avantor presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.38.

Avantor Trading Down 1.9 %

Shares of AVTR stock opened at $22.14 on Friday. The business has a 50-day moving average price of $21.46 and a two-hundred day moving average price of $23.34. Avantor, Inc. has a 12-month low of $19.59 and a 12-month high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The firm has a market cap of $15.07 billion, a P/E ratio of 48.13, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.